Stocks
GlaxoSmithKline (GSK) Revenue US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Revenue, £ | ? | 34 114 000 000 | 29 324 000 000 | 29 324 000 000 | 30 328 000 000 | 30 328 000 000 | 31 614 000 000 | ||
| Changes by years, y/y, % | 0% | -14% | 0% | +3% | 0% | -0.3% | |||
GlaxoSmithKline. Revenue US GAAP, £
GlaxoSmithKline. Revenue US GAAP, changes, %
GlaxoSmithKline. Revenue US GAAP, sum by quarters, £
GlaxoSmithKline (GSK) Revenue US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Revenue, £ | ? | 7 178 000 000 | 8 147 000 000 | 8 052 000 000 | 8 052 000 000 | 7 363 000 000 | 31 614 000 000 | |
| Changes by years, y/y, % | +4% | +4% | +9% | +9% | +6% | |||
| Changes by quarters, q/q, % | 0% | +13% | -1% | 0% | -9% | |||
